81 related articles for article (PubMed ID: 11755441)
1. Antimicrobial resistance of bacterial agents of the upper respiratory tract of school children in Buea, Cameroon.
Ndip RN; Ntiege EA; Ndip LM; Nkwelang G; Akoachere JF; Akenji T N
J Health Popul Nutr; 2008 Dec; 26(4):397-404. PubMed ID: 19069618
[TBL] [Abstract][Full Text] [Related]
2. [Current microbiological aspects of community respiratory infection beyond COVID-19].
Cantón R
Rev Esp Quimioter; 2021 Apr; 34(2):81-92. PubMed ID: 33749214
[TBL] [Abstract][Full Text] [Related]
3. Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?
Marchese A; Esposito S; Barbieri R; Bassetti M; Debbia E
BMC Infect Dis; 2012 Aug; 12():181. PubMed ID: 22866984
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Species-unique Peptide Biomarkers of Bacterial Pathogens by Tandem Mass Spectrometry-based Proteotyping.
Karlsson R; Thorsell A; Gomila M; Salvà-Serra F; Jakobsson HE; Gonzales-Siles L; Jaén-Luchoro D; Skovbjerg S; Fuchs J; Karlsson A; Boulund F; Johnning A; Kristiansson E; Moore ERB
Mol Cell Proteomics; 2020 Mar; 19(3):518-528. PubMed ID: 31941798
[TBL] [Abstract][Full Text] [Related]
5. Decalogue for the selection of oral antibiotics for lower respiratory tract infections.
Cantón R; Barberán J; Linares M; Molero JM; Rodríguez-González-Moro JM; Salavert M; González Del Castillo J
Rev Esp Quimioter; 2022 Feb; 35(1):16-29. PubMed ID: 35041328
[TBL] [Abstract][Full Text] [Related]
6. Respiratory infections in the community: evaluating current antibiotic options. Introduction.
Bartlett JG
Am J Med; 2010 Apr; 123(4 Suppl):S1-3. PubMed ID: 20350631
[No Abstract] [Full Text] [Related]
7. Editorial: Wastewater-based epidemiological surveillance of respiratory pathogens.
Champredon D; Vanrolleghem PA
Front Public Health; 2023; 11():1328452. PubMed ID: 38045979
[No Abstract] [Full Text] [Related]
8. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
Morrissey I; Robbins M; Viljoen L; Brown DF
J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic use in Hispanic households, New York city.
Larson E; Lin SX; Gomez-Duarte C
Emerg Infect Dis; 2003 Sep; 9(9):1096-102. PubMed ID: 14519246
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance in community-acquired respiratory tract pathogens.
Lark RL; Chenoweth C
Compr Ther; 1999 Jan; 25(1):20-9. PubMed ID: 9987589
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.
Felmingham D; Feldman C; Hryniewicz W; Klugman K; Kohno S; Low DE; Mendes C; Rodloff AC
Clin Microbiol Infect; 2002; 8 Suppl 2():12-42. PubMed ID: 12427206
[TBL] [Abstract][Full Text] [Related]
12. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
Ehrhardt AF; Russo R
Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
[TBL] [Abstract][Full Text] [Related]
13. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
14. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).
Mendes C; Marin ME; Quiñones F; Sifuentes-Osornio J; Siller CC; Castanheira M; Zoccoli CM; López H; Súcari A; Rossi F; Angulo GB; Segura AJ; Starling C; Mimica I; Felmingham D
Braz J Infect Dis; 2003 Feb; 7(1):44-61. PubMed ID: 12807691
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
